Sanofi India appoints Vaibhav Karandikar as Chief Financial Officer Ruchika Sharma6 Oct 2020 12:00 PM ISTMumbai: Drug major, Sanofi India has recently announced that the Board of Directors of the Company at its meeting held on 5 th October 2020 approved...
Sanofi Pasteur unveils DTaP-IPV booster vaccine for preschoolers in India Ruchika Sharma2 Oct 2020 9:30 AM ISTNew Delhi: Sanofi Pasteur India, vaccine unit of pharma firm Sanofi, on Wednesday said it has launched a booster vaccine for preschoolers to protect...
Sanofi concludes acquisition of Principia Biopharma Ruchika Sharma29 Sept 2020 11:00 AM ISTParis: Drugmaker, Sanofi, recently announced that the company has successfully concluded the acquisition of Principia Biopharma Inc. for $100 per...
GSK, Sanofi ink Covid-19 vaccine supply deal with Canada Ruchika Sharma27 Sept 2020 9:15 AM ISTParis and London: Sanofi and GSK have recently announced that they have signed agreements with the Government of Canada for the supply of up to...
Sanofi not involved in COVID-19 human challenge trial: Spokesman Ruchika Sharma25 Sept 2020 9:15 AM ISTParis: Sanofi is not involved in the COVID-19 human challenge trials reported to be launched in Britain and its potential vaccines are not being used...
Sanofi, Health2Sync ink pact for digital solution to diabetes management Ruchika Sharma20 Sept 2020 9:00 AM ISTTaipei: Health2Sync, a digital health startup, specializing in diabetes management, has entered into a partnership with Sanofi, a biopharmaceutical...
GSK, Sanofi to provide 300 million doses of COVID-19 vaccine to EU Ruchika Sharma19 Sept 2020 1:15 PM ISTA Phase 3 study is planned to begin by the end of 2020 and regulatory approval could be requested in the first half of 2021.
Sanofi Dupixent gets USFDA Breakthrough Therapy designation to treat eosinophilic esophagitis Ruchika Sharma16 Sept 2020 1:51 PM ISTParis: Drug major, Sanofi has recently secured Breakthrough Therapy designation from the U.S. Food and Drug Administration(USFDA) for its Dupixent (...
Sanofi Plans Ingredients Unit IPO Within Months: Report Ruchika Sharma7 Sept 2020 9:00 AM ISTParis: Sanofi, the French pharmaceutical giant, plans to sell shares in its drug-ingredients division in the next few months, a senior executive...
Sanofi COVID-19 drug Kevzara fails test, clinical trails halted Ruchika Sharma2 Sept 2020 5:12 PM ISTParis: In a major setback, French drugmaker Sanofi, recently announced that the company has halted the clinical trials of its COVID-19 drug Kevzara...
French drugmaker Sanofi more confident about its COVID vaccines: Report Farhat Nasim31 Aug 2020 9:45 AM IST“Our confidence has increased. We have work to do like everybody on manufacturing in large volumes. But we will have one, maybe two vaccines next...
Sanofi to begin tender offer to acquire Principia Biopharma Ruchika Sharma30 Aug 2020 9:45 AM ISTEvercore is acting as financial advisor to Sanofi and Weil, Gotshal & Manges LLP is acting as its legal counsel. Centerview Partners LLC and BofA...
